Hiv-remmers: verschil tussen versies
Verwijderde inhoud Toegevoegde inhoud
+TAF |
|||
Regel 31:
| [[Abacavir/lamivudine|Kivexa]] (EU)<br />[[Abacavir/lamivudine|Epzicom]] (VS) || [[abacavir]] + [[lamivudine]] || 2 augustus 2004 || [[GlaxoSmithKline]]
|-
| [[Tenofovir disoproxil/emtricitabine|Truvada]] || [[tenofovir disoproxil]] + [[emtricitabine]] || 2 augustus 2004 || [[Gilead Sciences]]
|-
| [[Emtricitabine/tenofovir disoproxil/efavirenz|Atripla]] || [[emtricitabine]] + [[efavirenz]] + [[tenofovir disoproxil]] || 12 juli 2006 || [[Gilead Sciences]] en <br />[[Bristol-Myers Squibb]]
|-
| [[Emtricitabine/rilpivirine/tenofovir disoproxil|Eviplera]] (EU)<br />[[Emtricitabine/rilpivirine/tenofovir|Complera]] (VS) || [[emtricitabine]] + [[rilpivirine]] + [[tenofovir disoproxil]] || 10 augustus 2011 || [[Gilead Sciences]] en <br />[[Tibotec]] ([[Johnson & Johnson]])
|-
| [[Elvitegravir/cobicistat/emtricitabine/tenofovir disoproxil|Stribild]] || [[elvitegravir]] + [[cobicistat]] + [[emtricitabine]] + [[tenofovir disoproxil]] || 27 augustus 2012 || [[Gilead Sciences]]
|-
| [[Abacavir/dolutegravir/lamivudine|Triumeq]] || [[abacavir]] + [[dolutegravir]] + [[lamivudine]] || 22 augustus 2014 || [[ViiV Healthcare]]
|-
| [[Elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide|Genvoya]] || [[elvitegravir]] + [[cobicistat]] + [[emtricitabine]] + [[tenofovir alafenamide]] || 5 november 2015 || [[Gilead Sciences]]
|-
| [[Tenofovir alafenamide/emtricitabine|Descovy]] || [[emtricitabine]] + [[tenofovir alafenamide]] || || [[Gilead Sciences]]
|-
| [[Emtricitabine/rilpivirine/tenofovir alafenamide|Odefsey]] || [[emtricitabine]] + [[rilpivirine]] + [[tenofovir alafenamide]] || 1 maart 2016 || [[Gilead Sciences]]
|}
===Prijs===
| |||